1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Liu Zhenhua: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer Fluzoparil, Anlotinib - Extensive Stage Small Cell Lung Cancer | Phase 2 | Unknown | Liu Zhenhua | 50 | 2021-06-01 | 2021-06-21 |
anlotinib (1)
China (1)
Wu Zhuang, Dr. (1)